pentobarbital will decrease the extent or result of buprenorphine, lengthy-acting injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Patients who transfer to buprenorphine extensive-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers needs to be monitored